BriaCell Therapeutics Corp. (TSX:BCT)
Canada · Delayed Price · Currency is CAD 5.65
-0.21 (-3.58%)
Mar 24, 2026, 3:53 PM EST
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of CAD 42.49 million as of March 24, 2026. Its market cap has increased by 123.27% in one year.
Market Cap
42.49M
Enterprise Value
973.21K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.65
Market Cap Chart
Since December 3, 2014, BriaCell Therapeutics's market cap has increased from 24.42M to 42.49M, an increase of 74.01%. That is a compound annual growth rate of 5.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 42.49M | 130.13% |
| Dec 31, 2025 | 18.46M | -48.44% |
| Dec 31, 2024 | 35.81M | -71.28% |
| Dec 29, 2023 | 124.66M | 36.15% |
| Dec 30, 2022 | 91.56M | -44.85% |
| Dec 31, 2021 | 166.03M | 3,496.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sharp Therapeutics | 67.67M |
| NurExone Biologic | 58.87M |
| Medicenna Therapeutics | 58.39M |
| Sernova Biotherapeutics | 52.16M |
| MedMira | 45.33M |
| Defence Therapeutics | 43.09M |
| Resverlogix | 34.78M |
| Microbix Biosystems | 34.56M |